Jinling Pharmaceutical Company Limited (SHE:000919)
8.58
-0.33 (-3.70%)
Apr 9, 2026, 3:04 PM CST
SHE:000919 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,517 | 1,771 | 1,548 | 1,495 | 1,502 |
Short-Term Investments | - | 165.22 | 337.45 | 250 | - |
Trading Asset Securities | 939.31 | 706.05 | 233.86 | 92.35 | 1.25 |
Cash & Short-Term Investments | 2,456 | 2,642 | 2,119 | 1,837 | 1,503 |
Cash Growth | -7.03% | 24.69% | 15.33% | 22.25% | 14.12% |
Accounts Receivable | 690.95 | 686.73 | 591.05 | 467.22 | 507.2 |
Other Receivables | 5.42 | 8.16 | 8.76 | 53.12 | 16.85 |
Receivables | 696.38 | 694.89 | 599.81 | 520.34 | 524.05 |
Inventory | 233.14 | 271.62 | 290.91 | 250.48 | 245.48 |
Prepaid Expenses | - | - | 0.15 | 1.16 | - |
Other Current Assets | 411.91 | 9.37 | 9.63 | 23.79 | 16.29 |
Total Current Assets | 3,798 | 3,618 | 3,020 | 2,633 | 2,289 |
Property, Plant & Equipment | 1,457 | 1,501 | 1,541 | 1,303 | 1,297 |
Long-Term Investments | 62.37 | 431.07 | 369.32 | 265.01 | 638.97 |
Goodwill | 44.37 | 62.42 | 148.72 | 27.33 | 18.05 |
Other Intangible Assets | 322.93 | 325.67 | 341.67 | 258.44 | 140.2 |
Long-Term Deferred Tax Assets | 12.61 | 12.49 | 16.61 | 28.54 | 19.62 |
Long-Term Deferred Charges | 120.55 | 83.34 | 13.94 | 18.26 | 17.85 |
Other Long-Term Assets | 189.19 | 54.49 | 42 | 10.7 | 26.96 |
Total Assets | 6,007 | 6,089 | 5,493 | 4,544 | 4,448 |
Accounts Payable | 554.97 | 595.31 | 546.69 | 454.04 | 479.36 |
Accrued Expenses | 98.2 | 212.46 | 224.73 | 219.95 | 207.27 |
Short-Term Debt | - | - | - | 1.48 | 15.01 |
Current Portion of Long-Term Debt | 8.74 | - | - | - | - |
Current Portion of Leases | - | 4.23 | 3.08 | 1.53 | 1.06 |
Current Income Taxes Payable | 58.62 | 35.53 | 37.97 | 48.38 | 43.09 |
Current Unearned Revenue | 19.57 | 35.6 | 17.65 | 22.14 | 26.9 |
Other Current Liabilities | 235.85 | 143.9 | 182.53 | 117.9 | 83.25 |
Total Current Liabilities | 975.95 | 1,027 | 1,013 | 865.42 | 855.95 |
Long-Term Debt | 150.1 | 150.12 | - | - | - |
Long-Term Leases | 32.98 | 34.85 | 38.6 | 2.29 | 0.59 |
Long-Term Unearned Revenue | 0.68 | 1 | 0.47 | 0.63 | 0.79 |
Long-Term Deferred Tax Liabilities | 25.01 | 27.28 | 28.72 | 48.98 | 55.77 |
Total Liabilities | 1,185 | 1,240 | 1,080 | 917.32 | 913.1 |
Common Stock | 621.92 | 623.71 | 511.14 | 510.4 | 504 |
Additional Paid-In Capital | 1,088 | 1,098 | 651.74 | 478.34 | 462.06 |
Retained Earnings | 2,065 | 2,073 | 2,095 | 2,025 | 1,958 |
Treasury Stock | - | -6.77 | -26.99 | -23.62 | - |
Comprehensive Income & Other | 2.66 | 3.09 | 3.42 | 4.17 | 3.29 |
Total Common Equity | 3,778 | 3,791 | 3,234 | 2,994 | 2,928 |
Minority Interest | 1,044 | 1,057 | 1,178 | 632.88 | 606.84 |
Shareholders' Equity | 4,822 | 4,849 | 4,412 | 3,627 | 3,535 |
Total Liabilities & Equity | 6,007 | 6,089 | 5,493 | 4,544 | 4,448 |
Total Debt | 191.82 | 189.21 | 41.67 | 5.3 | 16.66 |
Net Cash (Debt) | 2,265 | 2,453 | 2,077 | 1,832 | 1,486 |
Net Cash Growth | -7.68% | 18.08% | 13.39% | 23.26% | 12.85% |
Net Cash Per Share | 3.64 | 4.14 | 4.12 | 3.64 | 2.95 |
Filing Date Shares Outstanding | 622.06 | 623.71 | 629.06 | 488.88 | 510.4 |
Total Common Shares Outstanding | 622.06 | 623.71 | 511.14 | 488.88 | 504 |
Working Capital | 2,822 | 2,591 | 2,007 | 1,768 | 1,433 |
Book Value Per Share | 6.07 | 6.08 | 6.33 | 6.12 | 5.81 |
Tangible Book Value | 3,410 | 3,403 | 2,744 | 2,708 | 2,769 |
Tangible Book Value Per Share | 5.48 | 5.46 | 5.37 | 5.54 | 5.50 |
Buildings | - | 1,495 | 1,507 | 1,294 | 1,274 |
Machinery | - | 1,416 | 1,349 | 1,114 | 1,074 |
Construction In Progress | - | 71.78 | 84.2 | 37.84 | 28.78 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.